Compare ADSK & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADSK | BDX |
|---|---|---|
| Founded | 1982 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.3B | 54.6B |
| IPO Year | 1994 | 1998 |
| Metric | ADSK | BDX |
|---|---|---|
| Price | $242.56 | $194.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 36 | 16 |
| Target Price | ★ $307.54 | $195.57 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 11-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.15% |
| EPS Growth | ★ 2.15 | N/A |
| EPS | ★ 4.64 | 1.59 |
| Revenue | $7,206,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $15.52 | N/A |
| Revenue Next Year | $11.02 | $2.27 |
| P/E Ratio | ★ $52.22 | $122.83 |
| Revenue Growth | ★ 17.53 | 8.24 |
| 52 Week Low | $185.50 | $140.11 |
| 52 Week High | $320.00 | $213.08 |
| Indicator | ADSK | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.21 | 60.49 |
| Support Level | $241.33 | $175.60 |
| Resistance Level | $250.27 | $213.08 |
| Average True Range (ATR) | 7.17 | 3.72 |
| MACD | 0.90 | 0.53 |
| Stochastic Oscillator | 52.75 | 70.60 |
Founded in 1982, Autodesk is a multinational software company best known for pioneering computer-aided design, or CAD, with its AutoCAD product. Nowadays, Autodesk provides design software for a variety of verticals, including architecture & construction, manufacturing, and media & entertainment. Autodesk products have been used in some of the world's most iconic landmarks, like Burj Khalifa, and well-known movie titles like Avatar.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.